Xian Ping Lu
Directeur Général chez SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Fortune : 67 M $ au 30/04/2024
Profil
Xian Ping Lu is the founder of Shenzhen Chipscreen Biosciences Co., Ltd., where he currently holds the title of Chairman & General Manager since 2020.
He founded the company in 2001.
Dr. Lu is also the founder of Maxia Pharmaceuticals, Inc. Dr. Lu's former job was as a Research Director at Galderma Research & Development SNC.
Dr. Lu's education includes an undergraduate degree from Sichuan University in 1983, a graduate degree from Peking Union Medical College in 1986, and a doctorate degree from Peking Union Medical College in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 22 239 625 ( 5,41% ) | 67 M $ | 30/04/2024 |
Postes actifs de Xian Ping Lu
| Sociétés | Poste | Début |
|---|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Directeur Général | 24/03/2018 |
Anciens postes connus de Xian Ping Lu
| Sociétés | Poste | Fin |
|---|---|---|
Galderma Research & Development SNC
 Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The private company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Fondateur | - |
Formation de Xian Ping Lu
| Sichuan University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The private company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |
